Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Florida for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Florida only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Florida (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Aymen Kenawy (NPI 1770780603)

Field	Value
Entity Type	Individual
Organization	Aymen Kenawy
Address	3890 Jenks Ave
City	Lynn Haven
State	FL
ZIP	32444
Taxonomy	Rheumatology Physician
NPI Enumerated	July 3, 2007

Payer Source	Total Paid
Medicare	$5M
Medicaid	$0

Key Findings

This provider is effectively single‑payer in our file: total Medicare revenue is $5M and there is no Medicaid billing on file. The absence of Medicaid activity means analyses of payer mix, network participation, or dual‑eligible case management should treat this entity as Medicare‑dependent in the available data.

Revenue is highly concentrated in a small set of biologic/infusible drugs: the top 3 Medicare codes by revenue account for 67.0% of this provider's total Medicare revenue. Those top codes are J0129 (45.7%), J1602 (14.9%), and J0897 (6.4%), indicating a business model driven largely by high‑cost injectable therapies rather than a broad mix of low‑margin office procedures.

The CPT/HCPCS mix and high ranks point to a practice built around on‑site infusion and biologic administration. High revenue and counts for J0129, J1602, J3262, J9312 and J1745 alongside strong volumes for infusion administration codes such as 96365 and chemotherapy administration codes like 96413 indicate the provider operates substantial drug infusion services rather than only outpatient consults.

For several top drug codes this provider is a national outlier: J0129 ranks #3 of 1221 providers nationally (100th percentile; extreme outlier) and J1602 ranks #14 of 1041 providers nationally (99th percentile; extreme outlier). J0897 ranks #393 of 10057 providers nationally (96th percentile; notably above typical national volume), so the provider shows both extreme concentration and above‑typical utilization for select biologics at a national scale.

In addition to infusions, evaluation and management visits and imaging are notable revenue contributors: 99214 accounts for $195.6K (4.0% of Medicare revenue) and ranks #1124 of 479517 providers nationally (100th percentile; extreme outlier), while musculoskeletal ultrasound 76881 appears with $45.2K (0.9%) and ranks #19 of 1606 providers nationally (99th percentile; extreme outlier). These signals together suggest a high throughput of established patient visits combined with point‑of‑care diagnostic imaging.

The provider also reports substantial ordering/interpretation of rheumatologic labs and related diagnostics, supporting the specialty profile: 86235 ($35.8K revenue, 0.7%) ranks #89 of 746 providers nationally (88th percentile), 82306 ($26.9K, 0.6%) ranks #372 of 12453 providers nationally (97th percentile), and 86146 ($14.6K, 0.3%) ranks #47 of 195 providers nationally (76th percentile). Together these lab and test codes are consistent with longitudinal rheumatology care and disease‑monitoring workflows in the practice.

The provider’s NPI tenure is long‑standing: enumerated 2007-07-03 (~19 years ago), which is consistent with an established practice that could have built infusion capacity and referral relationships over time. That longevity helps explain the combination of high biologic volumes and supporting E/M, imaging, and lab services.

Because 67.0% of Medicare revenue is concentrated in three infusion/biologic drug codes, the provider’s financial profile is sensitive to changes in drug utilization, reimbursement rates, or site‑of‑service payment policy for those specific HCPCS codes. From a payer or competitive perspective, this pattern represents both a specialization advantage (ability to deliver high volumes of biologics) and a concentration risk if market or regulatory shifts affect those therapies or their administration reimbursement.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

65 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	66,930	$30	$2.2M
J1602	Injection, golimumab, 1 mg, for intravenous use	71,950	$10	$719.5K
J0897	Injection, denosumab, 1 mg	17,280	$20	$311K
J3262	Injection, tocilizumab, 1 mg	58,750	$10	$293.8K
J9312	Injection, rituximab, 10 mg	4,150	$60	$232.4K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	7,660	$30	$199.2K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	2,080	$90	$195.6K
J3111	Injection, romosozumab-aqqg, 1 mg	22,050	$10	$176.4K
95810	Polysomnography refers to the continuous and simultaneous monitoring and recording of various physiological and pathophysiological parameters of sleep for six or more hours with physician review,…	160	$440	$72.8K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	1,510	$50	$69.6K

Showing 1–10 of 65

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 65 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Florida Distribution

Aymen Kenawy — 7 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Florida

Full comparison — all codes billed, vs. state median

65 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	1	130	9,350	$30	$386.8K
J9312	12	30	3,730	$60	$253.2K
J3262	18	70	38,360	$1	$241.9K
J1602	1	90	13,930	$10	$184.6K
J3111	55	140	16,170	$10	$166.4K
J0897	73	1,060	3,290	$20	$106.5K
86480	7	20	90	$60	$87.3K
J1745	10	120	2,060	$30	$80.9K
86235	7	40	220	$20	$57.9K
86146	4	10	220	$20	$37K

Showing 1–10 of 65

Related Providers

Other providers that share a Tax Identification Number (TIN) with Aymen Kenawy, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Eugene Jalbert	FL	Rheumatology Physician	$1.8M	$0
Bilal Islam	FL	Sports Medicine (Family Medicine) Physician	$364.2K	$0
Amanda Simmons	FL	Family Nurse Practitioner	$83K	$0
Andrew Rising	FL	Family Nurse Practitioner	$57.4K	$0
Stephen Johnson	FL	Family Nurse Practitioner	$50.2K	$0

Nearby Providers

Other providers in the same ZIP code as Aymen Kenawy, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Hasan Murshed	FL	Radiation Oncology Physician	$1.2M	$0
Brannon Chester	FL	Physical Therapist	$123.8K	$0
John Gray	FL	Physical Therapist	$123.2K	$0
Marcus Kolmetz	FL	Audiologist	$58.5K	$0
Carlos Fernandez	FL	Medical Physician Assistant	$39.4K	$0

Aymen Kenawy — Billing Profile & Reimbursement Data

Sign up for Aymen Kenawy — Billing Profile & Reimbursement Data policy alerts

Aymen Kenawy — Billing Profile & Reimbursement Data

Sign up for Aymen Kenawy — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References